Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000904454-15-000219
Filing Date
2015-03-25
Accepted
2015-03-25 16:45:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A FOR ESPERION THERAPEUTICS, INC. BY DOMAIN PARTNERS VII, L.P. s13da_032515-esperion.htm SC 13D/A 87829
  Complete submission text file 0000904454-15-000219.txt   89340
Mailing Address ONE PALMER SQUARE SUITE 515 PRINCETON NJ 08542
Business Address ONE PALMER SQUARE SUITE 515 PRINCETON NJ 08542 609-683-5656
DOMAIN PARTERS VII L P (Filed by) CIK: 0001374150 (see all company filings)

EIN.: 000000000
Type: SC 13D/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87536 | Film No.: 15725144
SIC: 2834 Pharmaceutical Preparations